Ohio Invites Global Technology and Innovation Community to Advance Solutions to Curb Drug Abuse and Addiction

Mar 23, 2018 | News, Newsletter

Launch of the Second Phase of Ohio Opioid Technology Challenge

 

Lisa Colbert.
Ohio Development Services Agency.

 

Ohio is one step closer to finding new solutions in the battle against drug abuse and addiction. The second phase of the Ohio Opioid Technology Challenge will accelerate the development of technology in four innovation Challenges. The goal is that these technology-based discoveries will help prevent and treat addiction and overdoses.

“We were thrilled by the outpouring of ideas we received in the first phase of the Technology Challenge,” said Director David Goodman, chair of the Ohio Third Frontier Commission. “We’re eager to move forward with this next step in developing new solutions and saving lives.”

At the request of Ohio Governor John R. Kasich, the Ohio Opioid Technology Challenge leverages $8 million of a $20 million commitment to advance new ideas in the battle against drug abuse and addiction. The Challenge is a multi-phase prize competition with escalating prize amounts associated with progress toward developing solutions. The Idea Phase, which concluded in December 2017, collected bold and creative ideas from hundreds of researchers, caregivers, service providers and citizens from across Ohio, the U.S. and the world.

The Challenge Phase will tap the expertise of the worldwide business and innovation community to advance technical solutions in the following areas:

• Diagnose: Technologies to rapidly identify individuals at high risk of addiction or overdose. Solutions are expected to come from a variety of disciplines including IT, artificial intelligence, and biological or genetic diagnostics.

• Prevent: Technologies to eliminate or reduce urges, cravings or symptoms of withdrawal. Solutions are likely to be pharmaceuticals or medical devices that specifically address addictive responses but may also come from other behavior modification innovations.

• Connect: Technologies to provide immediate and extended access to help for relapse or overdose intervention. Expected solutions are likely to include communication or social media technologies that immediately connect individuals, including those in remote and rural areas, to needed resources.

• Protect: Technologies to protect first responders and medical professionals from inadvertent exposure to toxic opioid levels. Expected solutions are likely to include ambient detection of opioid residue, medical prophylactics, or protective equipment.

Responses for the Challenge Phase of the Ohio Opioid Technology Challenge may be submitted at www.opioidtechchallenge.com and are due by July 11, 2018 at 5:00 p.m. US EDT. For the Challenge Phase, up to 12 prize recipients will be announced in September 2018 and will receive $200,000 to advance their solutions. These semi-finalists will be eligible to compete in the final phase of the program, the Product Phase, to further develop their technology for market entry.

OEDA Launches COVID-19 Resource Center

OEDA has launched a COVID-19 Resource Center on its website. The Resource Center provides Ohio’s economic development community with resources to help practitioners best serve their business community during the COVID-19 outbreak.  OEDA will do all that we can to provide factual information and helpful resources you need as leaders in those efforts. 

read more

JobsOhio Actions Support Businesses During COVID-19 Crisis

JobsOhio has taken several actions to support Ohio businesses during the COVID-19 crisis.  JobsOhio has modified current programs and created temporary programs to provide flexibility and support cash needs of medium and small businesses.   These actions support a strategy to address immediate needs while looking toward the near future. 

read more

Central Ohio Battelle Receives Green Light to Decontaminate N95 Masks for Coronavirus

Central Ohio located Battelle received the go-ahead from the U.S. Food and Drug Administration to start decontaminating 80,000 used protective masks for healthcare workers treating coronavirus patients. after receiving the go-ahead late Sunday from the U.S. Food and Drug Administration for its newly developed technology. FDA had initially limited the use to 10,000 masks per day, and only in Battelle’s Central Ohio facilities.

read more